Eidos Therapeutics's activity chart (see below) currently has 31 price targets and 24 ratings on display.
Analysts' price targets on this stock were met 100% of the time, taking 408.13 days on average.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 27-Aug-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Dec-2020
$129
$73.26
5 years 10 months 24 days ago
(29-Dec-2020)
3/3 (100%)
$129 (0.00%)
66
Buy Since 17-Apr-2019
$56
6 years 4 days ago
(18-Nov-2020)
2/2 (100%)
$56 (0.00%)
533
Buy Since 21-Feb-2019
$73.26
$50
6 years 1 months 16 days ago
(06-Oct-2020)
3/3 (100%)
$73.26 (0.00%)
430
Buy Since 22-Jul-2019
$73.26
$80
6 years 1 months 17 days ago
(05-Oct-2020)
3/3 (100%)
$73.26 (0.00%)
307
Buy Since 30-Oct-2019
$73
$59
6 years 1 months 17 days ago
(05-Oct-2020)
3/3 (100%)
$73 (0.00%)
249
What is EIDX (Eidos Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on EIDX (Eidos Therapeutics)?
Which analyst has the lowest performance score on EIDX (Eidos Therapeutics) with a proven track record?
Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?
Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?
Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?